EC
CASC

EcoR1 Capital’s Cascadian Therapeutics, Inc. CASC Stock Holding History

EcoR1 Capital’s Portfolio CASC Stock Details CASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-3,000,000
Closed -$12.3M – 56
2017
Q3 		$12.3M Hold
3,000,000
– – 1.68% 18
2017
Q2 		$11.1M Hold
3,000,000
– – 2.57% 13
2017
Q1 		$12.4M Buy
+3,000,000
New +$12.6M 3.44% 10
2016
Q4 		– Hold
0
– – – 45
2016
Q3 		– Hold
0
– – – 53
2015
Q4 		– Sell
-157,250
Closed -$2.58M – 39
2015
Q3 		$2.58M Buy
+157,250
New +$3.22M 1.2% 15

Other funds holding CASC

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
SH
Sandia Holdings Greenwich, Connecticut $213M AUM 29.35% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return